Jeffrey DeSano

1.6k total citations · 1 hit paper
8 papers, 1.3k citations indexed

About

Jeffrey DeSano is a scholar working on Molecular Biology, Cancer Research and Complementary and alternative medicine. According to data from OpenAlex, Jeffrey DeSano has authored 8 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Complementary and alternative medicine. Recurrent topics in Jeffrey DeSano's work include Cell death mechanisms and regulation (4 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (2 papers). Jeffrey DeSano is often cited by papers focused on Cell death mechanisms and regulation (4 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (2 papers). Jeffrey DeSano collaborates with scholars based in United States and China. Jeffrey DeSano's co-authors include Liang Xu, Yang Meng, Daiming Fan, Min Zhang, Qing Ji, Xinbao Hao, Theodore S. Lawrence, Wenhua Tang, Ling Li and Debing Xiang and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jeffrey DeSano

7 papers receiving 1.3k citations

Hit Papers

MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-In... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey DeSano United States 7 1.0k 826 363 102 65 8 1.3k
Jingnan Shen China 17 939 0.9× 663 0.8× 206 0.6× 40 0.4× 76 1.2× 31 1.2k
Hongyan Jin China 20 879 0.9× 557 0.7× 219 0.6× 31 0.3× 111 1.7× 32 1.3k
Nermin Kahraman United States 16 686 0.7× 373 0.5× 151 0.4× 50 0.5× 90 1.4× 32 913
Shangke Huang China 13 421 0.4× 244 0.3× 274 0.8× 43 0.4× 110 1.7× 28 743
Nathalie Bauer Germany 14 432 0.4× 329 0.4× 246 0.7× 37 0.4× 77 1.2× 20 690
Meng-Ning Wei China 16 512 0.5× 215 0.3× 233 0.6× 66 0.6× 55 0.8× 23 770
Sima Orouei Iran 16 571 0.6× 379 0.5× 167 0.5× 27 0.3× 72 1.1× 19 848
Xianping Shi China 20 683 0.7× 148 0.2× 261 0.7× 66 0.6× 71 1.1× 35 1.0k
Gregory Zanieski United States 5 449 0.4× 470 0.6× 256 0.7× 18 0.2× 153 2.4× 8 738
Xinhan Zhao China 14 402 0.4× 211 0.3× 351 1.0× 45 0.4× 152 2.3× 26 861

Countries citing papers authored by Jeffrey DeSano

Since Specialization
Citations

This map shows the geographic impact of Jeffrey DeSano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey DeSano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey DeSano more than expected).

Fields of papers citing papers by Jeffrey DeSano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey DeSano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey DeSano. The network helps show where Jeffrey DeSano may publish in the future.

Co-authorship network of co-authors of Jeffrey DeSano

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey DeSano. A scholar is included among the top collaborators of Jeffrey DeSano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey DeSano. Jeffrey DeSano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
DeSano, Jeffrey, et al.. (2021). Total scrotal reconstruction following Fournier’s gangrene with bilateral prelaminated superior medial thigh flaps. BMJ Case Reports. 14(4). e240618–e240618.
2.
Dai, Yao, Jeffrey DeSano, Yang Qu, et al.. (2011). Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer.. PubMed. 1(2). 128–43. 49 indexed citations
3.
Dai, Yao, Jeffrey DeSano, Wenhua Tang, et al.. (2010). Natural Proteasome Inhibitor Celastrol Suppresses Androgen-Independent Prostate Cancer Progression by Modulating Apoptotic Proteins and NF-kappaB. PLoS ONE. 5(12). e14153–e14153. 130 indexed citations
4.
Dai, Yao, Jeffrey DeSano, Yang Meng, et al.. (2009). Celastrol Potentiates Radiotherapy by Impairment of DNA Damage Processing in Human Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 74(4). 1217–1225. 66 indexed citations
5.
DeSano, Jeffrey & Liang Xu. (2009). MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications. The AAPS Journal. 11(4). 682–92. 128 indexed citations
6.
Ji, Qing, Xinbao Hao, Min Zhang, et al.. (2009). MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells. PLoS ONE. 4(8). e6816–e6816. 558 indexed citations breakdown →
7.
Dai, Yao, Wenhua Tang, Jeffrey DeSano, et al.. (2008). Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis. Clinical Cancer Research. 14(23). 7701–7710. 50 indexed citations
8.
Ji, Qing, Xinbao Hao, Yang Meng, et al.. (2008). Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer. 8(1). 266–266. 338 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026